Efficacy of Furosemide versus KOH topical gels in treatment warts

Phase 3

Recruiting

• Conditions: on-genital warts.; Viral wart, unspecified; B07.9

• Registration Number: IRCT20120524009844N9
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Having at least 2 non-genital and non-flat warts
Satisfaction with the study
Age between 7 and 60 years

Exclusion Criteria

Pregnant and beast feeder women
Receive effective treatments for warts in the last 30 days
Having underlying cardiovascular, pulmonary or renal disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of warts. Timepoint: At the beginning of the study, 4 and 8 weeks after the intervention. Method of measurement: Physical examination.;Diameter of warts. Timepoint: At the beginning of the study, 4 and 8 weeks after the intervention. Method of measurement: Clinical examination and measurement with caliper.;Height of warts. Timepoint: At the beginning of the study, 4 and 8 weeks after the intervention. Method of measurement: Clinical examination and measurement with caliper.